The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodo...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical epidemiology Vol. 134; pp. 178 - 189
Main Authors Page, Matthew J., McKenzie, Joanne E., Bossuyt, Patrick M., Boutron, Isabelle, Hoffmann, Tammy C., Mulrow, Cynthia D., Shamseer, Larissa, Tetzlaff, Jennifer M., Akl, Elie A., Brennan, Sue E., Chou, Roger, Glanville, Julie, Grimshaw, Jeremy M., Hróbjartsson, Asbjørn, Lalu, Manoj M., Li, Tianjing, Loder, Elizabeth W., Mayo-Wilson, Evan, McDonald, Steve, McGuinness, Luke A., Stewart, Lesley A., Thomas, James, Tricco, Andrea C., Welch, Vivian A., Whiting, Penny, Moher, David
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2021
Elsevier Limited
Subjects
Checklist
Endorsements
Epidemiology
Estimates
Feedback
Identification methods
Internal Medicine
Literature reviews
Meta-analysis
Reporting guideline
Reproducibility
Systematic review
Terminology
Transparency
Checklist
Systematic review
Transparency
Reporting guideline
Reproducibility
Meta-analysis
Online AccessGet full text

Cover

More Information
Summary:The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:0895-4356
1878-5921
1878-5921
DOI:10.1016/j.jclinepi.2021.03.001